The role of cytogenetic abnormalities as a prognostic marker in primary myelofibrosis: applicability at the time of diagnosis and later during disease course

Although cytogenetic abnormalities are important prognostic factors in myeloid malignancies, they are not included in current prognostic scores for primary myelofibrosis (PMF). To determine their relevance in PMF, we retrospectively examined the impact of cytogenetic abnormalities and karyotypic evo...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Blood
Główni autorzy: Tam, Constantine S., Abruzzo, Lynne V., Lin, Katherine I., Cortes, Jorge, Lynn, Alice, Keating, Michael J., Thomas, Deborah A., Pierce, Sherry, Kantarjian, Hagop, Verstovsek, Srdan
Format: Artigo
Język:Inglês
Wydane: American Society of Hematology 2009
Hasła przedmiotowe:
Clinical Trials and Observations
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4828077/
https://ncbi.nlm.nih.gov/pubmed/19131547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-09-178541
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy